Intravenous Immunoglobulin for Acute Intracranial Hemorrhage
Status:
Unknown status
Trial end date:
2018-04-01
Target enrollment:
Participant gender:
Summary
This pilot study aims to investigate whether intravenous immunoglobulin is safe and effective
in alleviating perihematomal edema and neurologic deficits in patients with intracranial
hemorrhage.